Abingworth as of March 31, 2011
Portfolio Holdings for Abingworth
Abingworth holds 27 positions in its portfolio as reported in the March 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amarin Corporation | 45.0 | $88M | 12M | 7.30 | |
| Alnylam Pharmaceuticals (ALNY) | 8.8 | $17M | 1.8M | 9.56 | |
| Incyte Corporation (INCY) | 6.7 | $13M | 830k | 15.84 | |
| Zogenix | 5.9 | $12M | 2.3M | 4.98 | |
| Micromet | 4.8 | $9.4M | 1.7M | 5.60 | |
| OncoGenex Pharmaceuticals | 3.5 | $6.8M | 448k | 15.25 | |
| Nektar Therapeutics | 3.2 | $6.3M | 664k | 9.46 | |
| Celgene Corporation | 2.7 | $5.2M | 91k | 57.53 | |
| Alexza Pharmaceuticals | 2.5 | $4.8M | 2.9M | 1.69 | |
| NPS Pharmaceuticals | 2.4 | $4.8M | 498k | 9.57 | |
| Exelixis (EXEL) | 2.4 | $4.7M | 415k | 11.29 | |
| Caliper Life Sciences | 2.2 | $4.2M | 628k | 6.76 | |
| Novavax | 2.0 | $3.9M | 1.5M | 2.59 | |
| ISIS Pharmaceuticals | 1.2 | $2.4M | 268k | 9.03 | |
| Zalicus | 1.1 | $2.1M | 864k | 2.43 | |
| Cardiome Pharma Corp | 1.1 | $2.1M | 481k | 4.27 | |
| Medicines Company | 0.9 | $1.7M | 107k | 16.28 | |
| Celldex Therapeutics | 0.7 | $1.4M | 343k | 4.02 | |
| Affymetrix | 0.7 | $1.3M | 246k | 5.20 | |
| Isis Pharmaceuticals Inc Del note 2.625% 2/1 | 0.6 | $1.2M | 1.3k | 960.16 | |
| Allos Therapeutics | 0.4 | $837k | 265k | 3.16 | |
| Trimeris | 0.4 | $794k | 320k | 2.48 | |
| Cornerstone Therapeutics | 0.3 | $561k | 85k | 6.62 | |
| AVANIR Pharmaceuticals | 0.2 | $458k | 113k | 4.07 | |
| EntreMed | 0.2 | $362k | 71k | 5.12 | |
| Sunesis Pharmaceuticals | 0.1 | $248k | 129k | 1.92 | |
| Poniard Pharmaceuticals (PARD) | 0.0 | $77k | 182k | 0.42 |
